Full-Time

Network Operations Engineer

Posted on 4/12/2024

Penumbra Inc

Penumbra Inc

1,001-5,000 employees

Develops medical devices for vascular conditions

Compensation Overview

$119k - $155k/yr

Company Historically Provides H1B Sponsorship

Alameda, CA, USA

In Person

Category
🔒IT & Security (1)
Required Skills
Computer Networking
Requirements
  • A Bachelor’s degree in computer engineering or related field with 10+ years of experience, or equivalent combination of education and experience
  • 10+ years of experience in operations and managing Network devices, firewalls infrastructure
  • 10+ years of experience installing and building Network infrastructure
  • In-depth knowledge of network hardware and software technologies and best practices is required
  • R&S and/or DC CCNA is required, CCNP preferred
  • Good knowledge of PAN firewalls architecture, ACLs, policies, NATs, IPSEC VPNs, Global protect VPNs
  • Excellent troubleshooting skills in identifying and resolving complex networking issues
  • Strong understanding of how DNS works and experience in deploying and managing the internal and external DNS environments
  • Good team player and able to take accountability of tasks assigned and follow through to completion
  • Strong communication and customer facing skills (written, verbal, and formal presentation)
Responsibilities
  • Monitor network infrastructure, troubleshoot, and handle user incidents actively during company business hours
  • Provide medium to high complexity network support activities including occasional off-shift support in case of major outage reported
  • Work closely with Network Engineering, Network Security and Administration maintenance tasks and participate in process improvement
  • Perform medium to high complexity network changes and implementations
  • Participate in the network technology design process
  • Analyze potential changes and enhancements to network software and hardware to determine impact on existing production environment
  • Work as a member of a project team on business projects
Desired Qualifications
  • Knowledge of Routing and Switching design preferred
  • Experience on SolarWinds IT infrastructure monitoring and provisioning is preferred
  • LAN switching including VLAN, VTP, STP etc. is preferred
  • Solid understanding of routing protocols ISIS, OSPF, BGP is preferred
  • Understanding and practical experience with technologies such as Cisco SDA, ISE, VXLAN etc.
  • Good working knowledge of Wireless network includes WLC 9800, 3500 Access points 9120 is preferred
  • Solid knowledge of Cisco Catalyst 9000 series, Palo Alto firewalls, Nexus 93k series, APC UPS, OOB network is preferred
  • Test and validation experience (Network hardware or software/OS) is preferred
  • Experience in managing different Load Balancer solutions
  • Experience with cloud networking and cloud connectivity
  • Scripting/programing skills will be a PLUS
  • Medical device, pharmaceutical, biotech, or other regulated industry experience desired

Penumbra Inc. specializes in creating medical devices for treating neurovascular and peripheral vascular conditions. Their products, such as the Penumbra System and Indigo System, are designed to assist healthcare professionals in addressing issues like stroke and other vascular diseases. These devices work by providing advanced tools for interventions in neurology and vascular surgery, allowing for effective treatment options. Unlike many competitors, Penumbra focuses on a specific range of conditions and invests heavily in research and development to continuously enhance their offerings. The company's goal is to deliver high-quality medical devices that meet the needs of healthcare providers and improve patient outcomes.

Company Size

1,001-5,000

Company Stage

IPO

Headquarters

Alameda, California

Founded

2004

Simplify Jobs

Simplify's Take

What believers are saying

  • FDA clearance of Ruby XL System enhances Penumbra's product portfolio.
  • Increased adoption of AI in medical imaging complements Penumbra's neurovascular devices.
  • Telemedicine growth offers new integration opportunities for Penumbra's devices.

What critics are saying

  • Increased competition may impact Penumbra's market share in neurovascular devices.
  • Don Kassing's retirement could create a temporary leadership gap.
  • Italian regulatory challenges may affect Penumbra's financial performance.

What makes Penumbra Inc unique

  • Penumbra offers a comprehensive range of neuro and peripheral vascular devices.
  • The company focuses on innovative solutions for stroke and neurovascular disease treatment.
  • Penumbra's global presence spans North America, Europe, Asia, and Australia.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

401(k) Retirement Plan

401(k) Company Match

Paid Parental Leave

Paid Vacation

Paid Sick Leave

Paid Holidays

Growth & Insights and Company News

Headcount

6 month growth

↑ 0%

1 year growth

↑ 0%

2 year growth

↑ 0%
Medical Device Network
Jun 6th, 2025
Penumbra announces FDA clearance and launch of detachable embolisation coil

Penumbra has introduced Ruby XL System, the detachable embolisation coil, which has also received clearance from the US Food and Drug Administration (FDA).

BioSpace
Apr 29th, 2025
Penumbra, Inc. to Present at the BofA Securities 2025 Health Care Conference

ALAMEDA, Calif., April 29, 2025 /PRNewswire/ - Penumbra, Inc. (NYSE: PEN) today announced that its management team is scheduled to present at the BofA Securities 2025 Health Care Conference on Tuesday, May 13, 2025.

Neuro News International
Apr 24th, 2025
Penumbra announces Red 72 Silver Label product featuring company's latest engineering enhancements

Penumbra announces Red 72 Silver Label product featuring company's latest engineering enhancements.

PR Newswire
Apr 3rd, 2025
Penumbra, Inc. Schedules First Quarter 2025 Earnings Release And Conference Call For April 23, 2025

ALAMEDA, Calif., April 3, 2025 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that it will host a conference call to discuss financial results for the first quarter 2025 after market close on Wednesday, April 23, 2025 at 4:30 PM Eastern Time. A press release with first quarter 2025 financial results will be issued after market close that day.Webcast & Conference Call InformationThe conference call can be accessed live over the phone by dialing (888) 596-4144 (conference id: 6572573), or the webcast can be accessed on the "Events and Presentations" section under the "Investors" tab of the Company's website at www.penumbrainc.com. The webcast will be available on the Company's website for at least two weeks following the completion of the call.About PenumbraPenumbra, Inc., the world's leading thrombectomy company, is focused on developing the most innovative technologies for challenging medical conditions such as ischemic stroke, venous thromboembolism such as pulmonary embolism, and acute limb ischemia. Our broad portfolio, which includes computer assisted vacuum thrombectomy (CAVT), centers on removing blood clots from head-to-toe with speed, safety and simplicity. By pioneering these innovations, we support healthcare providers, hospitals and clinics in more than 100 countries, working to improve patient outcomes and quality of life

Penumbrainc
Mar 17th, 2025
Latest Data on Penumbra's CAVT Technology to Be Presented at SIR 2025: STRIDE, STRIKE-PE, and More

Latest data on Penumbra's CAVT technology to be presented at SIR 2025: STRIDE, STRIKE-PE, and more.

INACTIVE